Daily Cancer News
CancerConsultants provides summaries of new treatment strategies as they are discovered and reported by cancer physicians around the world. Our medical staff attends medical meetings worldwide and reviews medical literature daily to ensure appropriate news is provided to cancer patients and their families in a timely manner.
Cancer Consultants syndicated news service has been providing over 160 cancer advocacy, clinic, and hospital websites with an average of 550 news items per year since 1996. Subscribers include the Susan Komen Foundation, University of Florida Shands Cancer Center, The Prostate Cancer Research Foundation and leading clinics throughout the US.
News of the results of recent clinical trials evaluating cancer therapies and supportive care strategies serve to educate patients regarding new treatment strategies for cancer and facilitate discussions with their doctor. Importantly News also provides healthcare provider websites with fresh information daily which is key to ensuring patients use their website and enhancing search engine optimization.
Latest Cancer News
Three Studies Show Revlimid Provides Benefits—and Risks—in Multiple Myeloma (May 18, 2012)
Maintenance therapy with Revlimid® (lenalidomide) has been shown to significantly improve progression-free survival and time to progression in multiple myeloma, according to the results of three studies... Continue Reading
Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according... Continue Reading
Women are 30 percent more likely to survive melanoma than men, according to the results of a study published in the Journal of Clinical Oncology.[1] Melanoma is a deadly type of skin cancer that arises... Continue Reading
Patients with newly diagnosed multiple myeloma who receive Revlimid® (lenalidomide) may be at an increased risk of developing new cancers, according to a safety announcement released by the U.S. Food... Continue Reading
Younger patients with non-small cell lung cancer (NSCLC) are more likely to receive treatment than older patients, regardless of overall health and prognosis, according to the results of a study published... Continue Reading
The final analysis of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) indicated that vitamin E increased the risk of developing prostate cancer in otherwise healthy men by 17% when compared... Continue Reading
Low-dose radioiodine is as effective as high-dose in the treatment of thyroid cancer, according to the results of two separate studies published in the New England Journal of Medicine. The results mean... Continue Reading
Advances in Treatment Decision Making for Patients with Ductal Carcinoma In Situ- Live Web Chat with David Hyams, MDDr. Hyams has over 25 years of experience and has spent much of his career in academic... Continue Reading
The U.S. Food and Drug Administration (FDA) has approved a silicone gel-filled breast implant manufactured by Sientra Inc for breast augmentation in women at least 22 years old and breast reconstruction... Continue Reading
Chemo brain appears to correlate with long-term changes in the brain’s white matter, according to the results of a study published in the Journal of Clinical Oncology. Patients undergoing chemotherapy... Continue Reading
The U.S. Food and Drug Administration (FDA) has approved Votrient® (pazopanib) for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy. It is the first... Continue Reading
Inadequate pain treatment is a common and significant problem among cancer patients and the odds for under-treatment are twice as high for minorities, according to the results of a study published in the... Continue Reading
